Why Focus on Cancer Epigenetics? Unlike genetic mutations, epigenetic alterations change gene expression without altering DNA sequences, offering a new perspective on how cancer develops. Understanding these changes is key to developing innovative therapies, particularly for pediatric cancers, where alterations in transcription factors and chromatin regulators are common drivers.

We are honored to host four international experts who will share their insights:

• Iannis Aifantis, NYU, New York
• Judith Zaugg, Department of Biomedicine, Basel University
• Paola Scaffidi, IEO, Milan
• Alex Kentsis, MSKCC, New York

For more details and to confirm your participation, please visit the Symposium Website or Register Here.

We hope you can join us for this insightful event and contribute to the discussions on the future of cancer epigenetics.

Davide Seruggia, Eleni Tomazou, Florian Grebien, Kaan Boztug
St. Anna CCRI Symposium Hosts